News | Ultrasound Women's Health | May 16, 2022

BSC coordinates QUSTom, the first project that will use supercomputing to detect tumors more effectively and safely. The new imaging modality will improve breast cancer diagnosis and potentially replace mammograms

BSC coordinates QUSTom, the first project that will use supercomputing to detect tumors more effectively and safely. The new imaging modality will improve breast cancer diagnosis and potentially replace mammograms

May 16, 2022 — The Barcelona Supercomputing Center (BSC) coordinates QUSTom (Quantitative Ultrasound Stochastic Tomography), a new European project that aims to introduce a new medical imaging modality based for the first time on ultrasound and supercomputing, which will complement or even replace current techniques that use X-rays such as mammograms. This technology will be completely safe for patients as it does not use any type of radiation. It will also offer a superior image quality and better monitoring of tumors, among other advantages.

The algorithms that will be developed to obtain the medical images will offer two types of images simultaneously: the image of the patient's tissue, and the image of its associated uncertainty, which shows, pixel by pixel, how reliable the information is. The project also incorporates concepts such as multimodal imaging and real 3D imaging, which is an unprecedented combination in ultrasound breast imaging.

These algorithms, which will be developed using supercomputers within the BSC, will be inspired by others that have proven effective in completely different research areas such as the analysis of the earth's subsurface.

Apart from BSC, the project has five other partners: Karlsruher Institut für TechnologieVall d'Hebron Research Institute - VHIRArctur and the BSC and Imperial College London spin-off FrontWave Imaging, which is aligned with the objectives of this project, as well as Imperial College London itself as an associate partner.Therefore, physicists, engineers, operational experts and radiologists will work together to develop the next generation of radiation-free, accurate and scalable breast cancer diagnostic tools.

BSC researcher and project coordinator Josep de la Puente says: "QUSTom poses an excellent opportunity to bring ultrasound imaging to the next level. Interestingly enough, the revolution that we propose comes, not just from an extraordinary imaging device, but from the imaging algorithms used to generate unprecedented ultrasound images. Images that we can fairly compare to those obtained with MRI”.

The process of understanding, interpreting and configuring the images as a new diagnostic tool will be carried out by the team of Breast Imaging Radiologists from the Women's Radiology Service at Vall d'Hebron Hospital. "The development of this new technology will be carried out within the framework of the multimodal assessment that the team performs in the clinical care process as an integral part of the diagnosis and monitoring of breast cancer, all in the context of the Breast Pathology Unit," highlights Ana Rodríguez-Arana, head of the Women's Radiology Service at the Vall d'Hebron Hospital.

QUSTom has been selected to take part in the first call of the Pathfinder Open program of the European Innovation Council (EIC), funded by the European Union's Horizon Europe Framework Programme, which aims to support disruptive ideas and projects with great international potential. The project has been awarded with 2,744,300 euros over 2 years. In this first call the European Commission evaluated a total of 868 projects and finally only 56 were selected, 11 of them from Spain. In total, they will receive up to 168 million euros in funding.

Ultrasound to revolutionize diagnosis of the most common tumor

Breast cancer is the most frequently diagnosed type of tumor in the world, with 2.3 million women diagnosed in 2020 and 700,000 deaths due to this disease that same year. Early detection is therefore essential, since, if successful, survival at 5 years after diagnosis is as high as 90%.

Mammography is one of the most widely used methods to detect breast cancer and has saved millions of lives. However, there are studies that claim that it can give false positives and alert of a possible tumor that is not found later in the screening phase.

"We are very ambitious and plan for validation of the technology within the project's lifetime. We are also working on a roadmap towards its actual exploitation, we don't want this technology sitting in the lab. We are leaving no stone unturned towards satisfying what is, in our eyes, an urgent need for the female population worldwide. The challenge is huge but all of our partners and associates are extraordinarily committed and motivated towards our mission", concludes the BSC researcher Josep de la Puente.

For more information: https://qustom-project.eu/


Related Content

News | RSNA

December 1, 2023 — The Society of Breast Imaging (SBI) announced that Elizabeth Morris, MD, has been selected as the SBI ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Hologic, Inc. showcased several recent developments in next-generation AI solutions at the 109th ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
News | Breast Imaging

November 29, 2023 — A deep learning artificial intelligence (AI) model that was developed using only mammogram image ...

Time November 29, 2023
arrow
News | Artificial Intelligence

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and ...

Time November 28, 2023
arrow
News | RSNA

November 28, 2023 — iCAD, Inc., a global medical technology company developing cancer-detection solutions, will present ...

Time November 28, 2023
arrow
Feature | RSNA

November 27, 2023 — The collective anticipation of the radiology community was palpable from early morning through ...

Time November 27, 2023
arrow
News | RSNA

November 22, 2023 — ScreenPoint Medical has announced that its Transpara breast AI has surpassed 5 million mammograms ...

Time November 22, 2023
arrow
News | FDA

November 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time November 22, 2023
arrow
News | Breast Density

November 7, 2023 — Whiterabbit.ai, an AI-technology company dedicated to making late-stage diseases a rarity, announced ...

Time November 07, 2023
arrow
Subscribe Now